Elevated prodynorphin expression associated with ethanol withdrawal convulsions

Neurochemistry International

Volumn 37, Issue 5-6, 2000, Pages 463-472

  Beadles Bohling, A S ^a,b,c,d   Crabbe, J C ^a,b,c,d   Wiren, K M ^a,b,c,d  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b Neuroscience Program   (United States)

^c Res Serv P3 R D 39 3710 SW US V   (United States)

^d PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

Opioid receptors; Aversion; Convulsions; Ethanol; Genetics; Prodynorphin; Selected lines; Withdrawal

Indexed keywords

ALCOHOL; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; KAPPA OPIATE RECEPTOR; MESSENGER RNA; PRODYNORPHIN;

ALCOHOL BLOOD LEVEL; ALCOHOL WITHDRAWAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONVULSION; DISEASE SEVERITY; GENE EXPRESSION; GENETIC TRANSCRIPTION; GRAND MAL SEIZURE; HOUSEKEEPING GENE; LONG TERM EXPOSURE; MALE; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL;

ADMINISTRATION, INHALATION; ANIMALS; DISEASE SUSCEPTIBILITY; ENKEPHALINS; ETHANOL; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; MALE; MICE; MICE, INBRED STRAINS; PROTEIN PRECURSORS; RNA, MESSENGER; SEIZURES; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0034335361     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(00)00056-5     Document Type: Article

References (48)

1. Bansinath M., Ramabadran K., Turndorf H., Shukla V.K. Intracerebroventricular administration of kappa-agonists induces convulsions in mice. Brain Res. Bull. 27:1991;75-79.
2. Bausch S.B., Esteb T.M., Terman G.W., Chavkin C. Administered and endogenously released κ-opioids decrease pilocarpine-induced seizures and seizure-induced histopathology. J. Pharmacol. Exp. Ther. 284:1998;1147-1155.
3. Belknap J.K., Crabbe J.C., Young E.R. Voluntary consumption of ethanol in 15 inbred mouse strains. Psychopharmacology. 112:1993;503-510.
4. Caldecott-Hazard S., Engel J. Jr. Limbic postictal events: anatomical substrates and opioid receptor involvement. Prog. Neuropsychopharmacol. Biol. Psychiatry. 11:1987;389-418.
5. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
6. Civelli O., Douglass J., Goldstein A., Herbert E. Sequence and expression of the rat prodynorphin gene. Proc. Natl. Acad. Sci. USA. 82:1985;4291-4295.
7. Crabbe J.C. Genetic models of alcohol dependence. Alcohol Alcohol Suppl. 1:1987;103-108.
8. Crabbe J.C., Kosobud A., Young E.R. Genetic selection for ethanol withdrawal severity: differences in replicate lines. Life Sci. 33:1983;955-962.
9. Crabbe J.C., Kosobud A., Young E.R., Tam B.R., McSwigan J.D. Bidirectional selection for susceptibility to ethanol withdrawal seizures in Mus musculus. Behav. Genet. 15:1985;521-536.
10. Crabbe J.C., Merrill C.M., Kim D., Belknap J.K. Alcohol dependence and withdrawal: a genetic animal model. Ann. Med. 22:1990;259-263.
11. Crabbe J.C., Phillips T.J. Selective breeding for alcohol withdrawal severity. Behav. Genet. 23:1993;171-177.
12. Dhawan B.N., Cesselin F., Raghubir R., Reisine T., Bradley P.B., Portoghese P.S., Hamon M. International Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol. Rev. 48:1996;567-592.
13. Douglass J., Grimes L., Shook J., Lee P.H., Hong J.S. Systemic administration of kainic acid differentially regulates the levels of prodynorphin and proenkephalin mRNA and peptides in the rat hippocampus. Brain Res. Mol. Brain Res. 9:1991;79-86.
14. Feinberg A.P., Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:1983;6-13.
15. Fischer W., Bodewei R., Von Voigtlander P.F., Muller M. Anticonvulsant and related effects of U-54494A in various seizure tests. J. Pharmacol. Exp. Ther. 267:1993;163-170.
16. Fort P., Marty L., Piechaczyk M., Sabrouty S.E., Dani C., Jeanteur P., Blanchard J.M. Various rat tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res. 13:1985;1431-1435.
17. Frey H.H. Effect of μ- and κ-opioid agonists on the electroconvulsive seizure threshold in mice and antagonism by naloxone and MR 2266. Pharmacol. Toxicol. 62:1988;150-154.
18. Gale K. Progression and generalization of seizure discharge: anatomical and neurochemical substrates. Epilepsia. 29:(Suppl. 2):1988;S15-34.
19. Goldstein D.B. An animal model for testing effects of drugs on alcohol withdrawal reactions. J. Pharmacol. Exp. Ther. 183:1972;14-22.
20. Gulya K., Orpana A.K., Sikela J.M., Hoffman P.L. Prodynorphin and vasopressin mRNA levels are differentially affected by chronic ethanol ingestion in the mouse. Brain Res. Mol. Brain Res. 20:1993;1-8.
21. Harrison M.B., Shumate M.D., Lothman E.W. Opioid peptide expression in models of chronic temporal lobe epilepsy. Neuroscience. 65:1995;785-795.
22. Hauser W.A. Epidemiology of alcohol use and of epilepsy: the magnitude of the problem. Porter R.J., Mattson R.H., Cramer J.A., Diamond I. Alcohol and Seizures. 1990;12-21 F.A. Davis Co, Philadelphia.
23. Herz A. Endogenous opioid systems and alcohol addiction. Psychopharmacology (Berl.). 129:1997;99-111.
24. Himmelsbach C.K. Clinical studies of drug addiction. Archives of Internal Medicine. 69:1942;766.
25. Hong J.S., McGinty J.F., Lee P.H., Xie C.W., Mitchell C.L. Relationship between hippocampal opioid peptides and seizures. Prog. Neurobiol. 40:1993;507-528.
26. Hosford D.A., Caddick S.J., Lin F.H. Generalized epilepsies: emerging insights into cellular and genetic mechanisms. Curr. Opin. Neurol. 10:1997;115-120.
27. Kai T., Onishi H., Koide S., Katayama M., Yamagami S. Developmental and regional alteration of kappa-opioid receptors in seizure-susceptible EL mouse brain. Neurochem. Res. 23:1998;163-168.
28. Khachaturian H., Lewis M.E., Schafer M.K.-H., Watson S.J. Anatomy of the CNS opioid systems. Trends Neurosci. 10:1985;111-119.
29. Kosobud A., Crabbe J.C. Ethanol withdrawal in mice bred to be genetically prone or resistant to ethanol withdrawal seizures. J. Pharmacol. Exp. Ther. 238:1986;170-177.
30. Lason W., Przewlocka B., Stala L., Przewlocki R. Changes in hippocampal immunoreactive dynorphin and neoendorphin content following intra-amygdalar kainic acid-induced seizures. Neuropeptides. 3:1983;399-404.
31. Lee R.J., Hong J.S., McGinty J.F., Lomax P. Increased enkephalin and dynorphin immunoreactivity in the hippocampus of seizure sensitive Mongolian gerbils. Brain Res. 401:1987;353-358.
32. Lothman E.W. Basic mechanisms of seizure expression. Epilepsy Res. Suppl. 11:1996;9-16.
33. Mansour A., Khachaturian H., Lewis M.E., Akil H., Watson S.J. Anatomy of CNS opioid receptors. Trends Neurosci. 11:1988;308-314.
34. McClearn G.E., Rodgers D.A. Differences in alcohol preference among inbred strains of mice. Q.J. Stud. Alcohol. 20:1959;691-695.
35. Plotkin S.R., Banks W.A., Kastin A.J. Enkephalin, PPE mRNA, and PTS-1 in alcohol Withdrawal Seizure-Prone and -Resistant mice. Alcohol. 15:1998;25-31.
36. Przewlocka B., Lason W., Przewlocki R. Repeated ethanol administration decreases prodynorphin biosynthesis in the rat hippocampus. Neurosci. Lett. 134:1992;195-198.
37. Przewlocka B., Lason W., Przewlocki R. Repeated ethanol differently affects opioid peptide biosynthesis in the rat pituitary. Neuroendocrinology. 60:1994;331-336.
38. Przewlocka B., Machelska H., Lason W. Kappa opioid receptor agonists inhibit the pilocarpine-induced seizures and toxicity in the mouse. Eur. Neuropsychopharmacol. 4:1994;527-533.
39. Przewlocka B., Turchan J., Lason W., Przewlocki R. Ethanol withdrawal enhances the prodynorphin system activity in the rat nucleus accumbens. Neurosci. Lett. 238:1997;13-16.
40. Romualdi P., Donatini A., Bregola G., Bianchi C., Beani L., Ferri S., Simonato M. Early changes in prodynorphin mRNA and ir-dynorphin A levels after kindled seizures in the rat. Eur.J. Neurosci. 7:1995;1850-1856.
41. Simonato, M., Romualdi, P., 1996. Dynorphin and epilepsy [published erratum appears in Prog. Neurobiol. 1997, 51 (2), 223-224]. Prog. Neurobiol. 50, 557-583.
42. Simonato, M., Romualdi, P., 1996. Dynorphin and epilepsy [published erratum appears in Prog. Neurobiol. 1997, 51 (2), 223-224]. Prog. Neurobiol. 50, 557-583.
43. Simonato, M., Romualdi, P., 1996. Dynorphin and epilepsy [published erratum appears in Prog. Neurobiol. 1997, 51 (2), 223-224]. Prog. Neurobiol. 50, 557-583.
44. Terdal E.S., Crabbe J.C. Indexing withdrawal in mice: matching genotypes for exposure in studies using ethanol vapor inhalation. Alcohol Clin. Exp. Res. 18:1994;542-547.
45. Tortella F.C., Long J.B., Holaday J.W. Endogenous opioid systems: physiological role in the self-limitation of seizures. Brain Res. 332:1985;174-178.
46. Victor M. Alcohol withdrawal seizures: an overview. Porter R.J., Mattson R.H., Cramer J.A., Diamond I. Alcohol and Seizures. 1990;148-161 F.A. Davis Co, Philadelphia.
47. Victor M., Adams R.D. The effect of ethanol on the nervous system. Research Publications of the Association of Research on Nervous and Mental Disorders. 32:1953;526-573.
48. Xie C.W., Lee P.H., Douglass J., Crain B., Hong J.S. Deep prepiriform cortex kindling differentially alters the levels of prodynorphin mRNA in rat hippocampus and striatum. Brain Res. 495:1989;156-160.